Pravin Dugel Ocular Therapeutix, Inc (OCUL) insider trading activity

Pravin Dugel is Director of OCULAR THERAPEUTIX, INC. Currently has a direct ownership of 3.5 Million shares of OCUL, which is worth approximately $27.6 Million. The most recent transaction as insider was on May 23, 2025, when has been sold 21,219 shares (Common Stock) at a price of $7.18 per share, resulting in proceeds of $152,352. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.5M

0.6% 3M change

319.88% 12M change

Total Value Held $27.6 Million

Pravin Dugel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2025	SELL Open market or private sale	$152,352 $7.18 p/Share	21,219 Reduced 0.6%	3,499,099 Common Stock
Feb 24 2025	SELL Open market or private sale	$147,533 $6.87 p/Share	21,475 Reduced 0.61%	3,520,318 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	2,750,000 Added 43.71%	3,541,793 Common Stock
Nov 25 2024	SELL Open market or private sale	$186,326 $9.01 p/Share	20,680 Reduced 2.55%	791,793 Common Stock
Aug 23 2024	SELL Open market or private sale	$188,337 $9.02 p/Share	20,880 Reduced 2.51%	812,473 Common Stock
May 23 2024	SELL Open market or private sale	$125,214 $5.79 p/Share	21,626 Reduced 2.53%	833,353 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	854,979 Added 50.0%	854,979 Common Stock

Also insider at

ISEE

IVERIC bio, Inc. Healthcare

President

AADI

Aadi Bioscience, Inc. Healthcare

Director

Pravin Dugel

Director

Parsippany, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OCUL shares.

Notify only if

Value

Insider Trading

Get notified when an Ocular Therapeutix, Inc insider buys or sells OCUL shares.

Notify only if

Operation

Value

Type

News

Receive news related to OCULAR THERAPEUTIX, INC

Track Activities on OCUL

Account